Dare Bioscience Competitors and Similar CompaniesClear all

Dare Bioscience's competitors and similar companies include Greenwich LifeSciences, Nanospectra Biosciences and NexImmune.
Dare Bioscience
Dare Bioscience
Dare Bioscience (formerly Cerulean Pharma) develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
Greenwich LifeSciences
Greenwich LifeSciences
Greenwich LifeSciences is a clinical-stage biopharmaceutical company.
Nanospectra Biosciences
Nanospectra Biosciences
Nanospectra Biosciences is a company specializing in nanomedicine for selective thermal ablation.
NexImmune
NexImmune
NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform.
Founding Date
Founding Date
2006
Founding Date
2006
Founding Date
2002
Founding Date
2011
Type
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Locations
Stafford, US HQ
Locations
Houston, US HQ
Locations
Gaithersburg, US HQ
Employees
Employees
980% increase
Employees
433% increase
Employees
6
Employees
5032% decrease
Valuation ($)
Valuation ($)
33.8 m
Valuation ($)
186 m
Valuation ($)
N/A
Valuation ($)
372.4 k

Financial

Net income
Net income
($13.4m) (FY, 2025)
Net income
($15.8m) (FY, 2024)
Net income
N/A
Net income
($32.3m) (FY, 2023)

Funding

Total funding raised
Total funding raised
$ 115.7m
Total funding raised
N/A
Total funding raised
$ 4.3m
Total funding raised
$ 33.8m
For sources of this data, please see the company profile

View Company Profiles

Greenwich LifeSciences
HQ
Stafford, US
Employees
4↑ 33% increase

Greenwich LifeSciences is a clinical-stage biopharmaceutical company.

View company
Nanospectra Biosciences
HQ
Houston, US
Employees
6

Nanospectra Biosciences is a company specializing in nanomedicine for selective thermal ablation.

View company
NexImmune
HQ
Gaithersburg, US
Employees
50↓ 32% decrease

NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform.

View company